These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10795554)

  • 1. Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial.
    Goebel C; Hardt P; Doppl W; Temme H; Hackstein N; Klör HU
    Eur Radiol; 2000; 10(4):677-80. PubMed ID: 10795554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects of the use of non-ionic X-ray contrast substances during endoscopic retrograde cholangiopancreatography].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2003; (6):62-3. PubMed ID: 14674360
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).
    Kruse A; Brock A; Rodenberg J; Nowakowska-Duawa E; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S131-4. PubMed ID: 9204355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
    Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography.
    Jensen AR; Malchow-Møller A; Matzen P; Larsen JE; Møller F; Andersen JR; Magid E
    Scand J Gastroenterol; 1985 Jan; 20(1):83-6. PubMed ID: 2581308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
    Sand J; Nordback I
    Digestion; 1993; 54(2):105-11. PubMed ID: 8319838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of common factors for post endoscopic retrograde cholangiopancreatography pancreatitis.
    Haqqi SA; Mansoor-ul-Haq M; Shaikh H
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):464-7. PubMed ID: 21798131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
    Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
    Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospects of the use of non-ionic X-ray contrast media during endoscopic retrograde cholangiopancreatography].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2002; (6):62-3. PubMed ID: 12722628
    [No Abstract]   [Full Text] [Related]  

  • 12. Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial.
    Ogura T; Imoto A; Okuda A; Fukunishi S; Higuchi K
    Dig Dis; 2019; 37(3):255-261. PubMed ID: 30654370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group.
    Johnson GK; Geenen JE; Bedford RA; Johanson J; Cass O; Sherman S; Hogan WJ; Ryan M; Silverman W; Edmundowicz S
    Gastrointest Endosc; 1995 Oct; 42(4):312-6. PubMed ID: 8536898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of iotrolan and iohexol in lumbar myelography.
    Wagner A; Jensen C; Saebye A; Rasmussen TB
    Acta Radiol; 1994 Mar; 35(2):182-5. PubMed ID: 8172748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent.
    Sherman S; Hawes RH; Rathgaber SW; Uzer MF; Smith MT; Khusro QE; Silverman WB; Earle DT; Lehman GA
    Gastrointest Endosc; 1994; 40(4):422-7. PubMed ID: 7926531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of radiographic contrast media on pulmonary vascular resistance of normoxic and chronically hypoxic pulmonary hypertensive rats.
    Emery CJ; Fang L; Laude EA; Morcos SK
    Br J Radiol; 2001 Dec; 74(888):1109-17. PubMed ID: 11777768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic quality in endoscopic retrograde cholangiopancreatography: comparison between lodixanol and lopromide.
    Martin DF; England RE; Rösch T; Biehl E; Jeschke B; Heldwein D; Klauser A; Klaveness A; Kristoffersen D
    Endoscopy; 2000 Oct; 32(10):783-7. PubMed ID: 11068838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass.
    Lim CH; Jahansouz C; Freeman ML; Leslie DB; Ikramuddin S; Amateau SK
    Obes Surg; 2017 Oct; 27(10):2656-2662. PubMed ID: 28488091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model.
    Pfau PR; Mosley RG; Said A; Gopal DV; Fischer MC; Oberley T; Weiss J; Lee FT; Eckoff D; Reichelderfer M
    JOP; 2006 Jan; 7(1):27-33. PubMed ID: 16407615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.